Testing effectiveness (Phase 2)Study completedNCT02045212
What this trial is testing
Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).
Who this might be right for
Non-arteritic Ischemic Optic NeuropathyOptic Nerve Injuries
Regenera Pharma Ltd 22